CoreAge Rx vs LevelsRx
Two GLP-1 providers, one scoreboard. We put CoreAge Rx and LevelsRx head-to-head on the published Brief Score — the same six factors, scored the same way.
CoreAge Rx
The verdict
CoreAge Rx takes this head-to-head.
CoreAge Rx scores 94 to 64 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.
That doesn't make LevelsRx a bad call — it's best for people seeking support alongside compounded injections who can confirm the renewal price, phone cancellation process and guarantee requirements. Weigh the six factors below against your own priorities before you decide.
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.
Factor by factor
Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.
Price, coverage & the tracker
| Compare | CoreAge Rx | LevelsRx |
|---|---|---|
| Brief Score | 94/100 (A) | 64/100 (C) |
| Semaglutide | From $79/mo Annual offer: 12 months paid upfront, from $948. Main site: from $99/mo; confirm the selected offer. Full price detailsFrom $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo | From $129 first month; renewal unconfirmed Compounded weekly injection; advertised medication, supplies, coaching and delivery included. Complete continuing-plan and selected-dose charge unconfirmed. Cancel by phone at least seven days before billing. Conditional six-month medication-fee guarantee excludes coaching; damaged/incorrect shipment reports due within 24 hours. Full price detailsCompounded semaglutide weekly injection offered; complete continuing-plan quote unknown; from $129 first month with medication, supplies, coaching and delivery advertised, renewal amount unconfirmed |
| Tirzepatide | From $129/mo Annual offer: 12 months paid upfront, from $1,548. Main site: from $149/mo; confirm the selected offer. Full price detailsFrom $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo | From $169 first month; renewal unconfirmed Compounded weekly injection; advertised medication, supplies, coaching and delivery included. Complete continuing-plan and selected-dose charge unconfirmed. Cancel by phone at least seven days before billing. Conditional six-month medication-fee guarantee excludes coaching; damaged/incorrect shipment reports due within 24 hours. Full price detailsCompounded tirzepatide weekly injection offered; complete continuing-plan quote unknown; from $169 first month with medication, supplies, coaching and delivery advertised, renewal amount unconfirmed |
| Coverage | US only; restrictions by state, confirmed at intake | Most U.S. states advertised; the selected clinician, pharmacy and patient-state eligibility require confirmation |
| Brand-name access | Not confirmed | The reviewed current treatment offer is compounded; brand-name trial discussion does not establish a branded prescription offer. |
| Oral / sublingual | Injection only | Unconfirmed |
| On the tracker | Stableprice stable | Newnew to the tracker, no prior reading |
CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.
LevelsRx: First month from $129 semaglutide/$169 tirzepatide; renewal quote unconfirmed. Phone cancellation needs seven days notice. Conditional six-month guarantee excludes coaching; damage reports due within 24 hours.
Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.